indispensable health

AUGUST 14, 2023

Clear Communication**: An organized agenda ensures that all topics are clearly outlined. It guides the meeting towards discussing high-priority issues, preventing valuable time from being wasted on less pertinent topics. Time Allocation**: Assign time limits to each agenda item to prevent overindulgence in any one topic.

Hospitals 98

Hospitals Patient Care Communication 98

Outsourcing Pharma

DECEMBER 15, 2020

Sanofi has made a new five-year, $25m partnership agreement with the World Health Organization (WHO) to fight Neglected Topical Diseases (NTD); and eliminate sleeping sickness by 2030.

52

52

ISPE

SEPTEMBER 15, 2023

The Regulatory, Compliance, and Quality sessions, promise to be a comprehensive exploration of the vital topics shaping the pharmaceutical landscape. With topics ranging from advanced innovation to global structured submissions, these sessions will provide a comprehensive overview of the strides being made towards harmonization.

FDA 98

FDA Pharmaceutical Companies Pharmaceutical Companies Patient Care 98

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. Topic sponsors are not involved in the creation of editorial content.

Vaccines 98

Vaccines Immunization 98

Pharmaceutical Technology

NOVEMBER 16, 2022

ElevateBio has entered a partnership with Affini-T Therapeutics to progress the latter’s engineered TCR-T therapies focused on Kirsten rat sarcoma viral oncogene homolog (KRAS), a dominant oncogenic driver mutation in solid tumours. Topic sponsors are not involved in the creation of editorial content.

Immunization 98

Immunization 98

European Pharmaceutical Review

OCTOBER 13, 2022

The first focus will be to improve how work related to COVID-19 is handled: interactions with regulators, prioritising topics, managing medicines with no marketing authorisation, planning for HTAs and economic modelling methods. The bodies will work collectively on scientific and methodological topics to address these difficulties.

Communication 82

Communication 82

Pharmaceutical Technology

MAY 24, 2023

The BGTC is part of the accelerating medicines partnership (AMP) programme and is managed by the Foundation for the National Institutes of Health (FNIH). Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

FDA 96

FDA 96

Pharmaceutical Technology

MAY 18, 2023

KSQ Therapeutics has announced the expansion of its immuno-oncology strategic partnership with Takeda for new tumour-intrinsic targets. This partnership will focus on the identification and validation of new targets to inform treatment developments that address resistance mechanisms in cancer patients.

Immunization 52

Immunization 52

pharmaphorum

JUNE 4, 2021

With the likes of Amgen , Bristol-Myers Squibb , Novartis and Noxopharm , this intimate, industry-led forum will not only bring you up-to-speed with the latest developments from those pioneering the field, but also allow you to connect with your peers to build meaningful partnerships. Bringing theranostics to prostate cancer.

98

98

Pharmaceutical Technology

MARCH 29, 2023

The partnership will combine the VelociSuite technologies of Regeneron with Sonoma Biotherapeutics’ pioneering approach to develop and produce gene modified Treg cell therapies. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

98

98

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore. Topic sponsors are not involved in the creation of editorial content.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

OCTOBER 28, 2022

In the initial stage, the partnership will focus on the MAGE-A4 TCR programme of 2seventy bio in solid tumours. This programme is currently being developed under a partnership with Regeneron. According to the deal, JW Therapeutics will receive a licence from 2seventy for the MAGE-A4 cell therapy in the partnership regions.

52

52

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics and Eli Lilly and Company ’s wholly owned subsidiary Prevail Therapeutics have announced a partnership for the development of non-invasive gene therapies for central nervous system (CNS) diseases. Topic sponsors are not involved in the creation of editorial content.

Communication 95

Communication 95

Pharmaceutical Technology

JUNE 29, 2022

Terumo Blood and Cell Technologies and BioBridge Global subsidiary, GenCure, have entered a new partnership agreement to expand and integrate cell and gene therapy manufacturing solutions. The three-year partnership is planned to be conducted in two phases. Topic sponsors are not involved in the creation of editorial content.

105

105

Pharmaceutical Technology

APRIL 13, 2023

This agreement with Leucid Bio is an opportunity for ImaginAb to continue expanding our partnerships, and showcases the increasing adoption of our CD8 ImmunoPET technology.” Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Labelling 52

Labelling Immunization 52

Pharmaceutical Technology

DECEMBER 12, 2022

Gilead company Kite has entered an international strategic partnership with Arcellx for the joint development and commercialisation of the latter’s T-cell therapy, CART-ddBCMA, to treat relapsed or refractory multiple myeloma patients. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

Communication 105

Communication 105

Pharmaceutical Technology

JUNE 19, 2023

This partnership also provides a unique model for industry–academia collaboration and how we can leverage strengths from both sections for the benefit of patients.” Topic sponsors are not involved in the creation of editorial content. The company will also establish a GMP facility at IIT Kanpur’s Techno Park facility.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

OCTOBER 5, 2022

miRecule and Sanofi have entered a strategic partnership and exclusive licence agreement for the development and commercialisation of an antibody-RNA conjugate (ARC) to treat facioscapulohumeral muscular dystrophy (FSHD). Topic sponsors are not involved in the creation of editorial content.

52

52

Roots Analysis

AUGUST 1, 2023

These partnerships combine different expertise and resources to overcome challenges in operating medical drones. It is interesting to note that, recently several players have inked partnerships with government organizations for the purpose of medical drone delivery. appeared first on Blog.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

JULY 12, 2022

Furthermore, through the takeover, Vertex will obtain access to new hypoimmune stem cell assets under the ViaCyte-CRISPR Therapeutics partnership. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

110

110

Pharmaceutical Technology

JUNE 1, 2023

CPI intracellular drug discovery centre head Dr Juliana Haggerty said: “We’re excited to be leading this novel partnership, bringing together leading experts in intracellular drug delivery. Topic sponsors are not involved in the creation of editorial content.

Vaccines 97

Vaccines 97

pharmaphorum

NOVEMBER 2, 2021

The approach has become a hot topic in biopharma with a string of big ticket partnerships over the last couple of years, including a $2.4 The approach has become a hot topic in biopharma with a string of big ticket partnerships over the last couple of years, including a $2.4 Others include a $1.6

95

95

Pharmaceutical Technology

SEPTEMBER 9, 2022

The expanded partnership will combine the scientific expertise and investment of AstraZeneca in RNA therapeutics with Gatehouse Bio’s capabilities in developing disease-modifying small RNA compounds. Topic sponsors are not involved in the creation of editorial content.

Compounding 98

Compounding 98

Pharmaceutical Technology

OCTOBER 25, 2022

Taysha is an industry leader in CNS gene therapies, and this partnership fits strategically with our long-term vision of expanding Astellas’ gene therapy capabilities, allowing the company to impact the lives of a broader range of patients with urgent unmet medical needs.”. Topic sponsors are not involved in the creation of editorial content.

105

105

Roots Analysis

AUGUST 14, 2023

Additionally, majority of partnerships are R&D agreements, followed by licensing deals; most of the licensing deals are focused on the licensing of TCR technologies.

52

52

Roots Analysis

AUGUST 9, 2023

Recent Activity in Partnerships and Collaborations Manufacturing execution systems is a technically complex and financially demanding solution; as a result, healthcare stakeholders prefer to rely on speciality service providers that claim to have the required expertise. Below, I have pasted figure that depicts our proprietary framework.

Documentation 52

Documentation Communication 52

Pharmaceutical Technology

AUGUST 4, 2022

Poseida Therapeutics and Roche have signed a strategic partnership and licence agreement to develop allogeneic CAR-T cell therapies for hematologic malignancies. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

59

59

Pharmaceutical Technology

APRIL 14, 2023

In July last year, Twist announced a partnership with Ildong to develop antibodies for use in immuno-oncology. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

98

98

DiversifyRx

MARCH 22, 2024

Tips and advice on health topics related to your special services can help cement your reputation as a trustworthy authority in your community. You know more about a thousand topics than they ever will. If you want to attract families with kids, then partnering with a daycare or preschool is a perfect partnership.

Independent Pharmacies 52

Independent Pharmacies Customer Service Packaging Communication 52

Pharmaceutical Technology

OCTOBER 27, 2022

Candel Therapeutics has entered a partnership with the University of Pennsylvania (Penn) in the US to assess the effect of new viral immunotherapies to enhance the impacts of the latter’s CAR-T cell therapies in solid tumour models. Topic sponsors are not involved in the creation of editorial content.

52

52

Roots Analysis

AUGUST 16, 2023

TIL Therapies – Partnerships and Collaborations A growing interest in this field is reflected from the increase in the partnerships focused on R&D, representing close to 40% of the total partnerships, involving both international and indigenous stakeholders.

52

52

Pharmaceutical Technology

AUGUST 17, 2022

Merck (MSD outside North America) has entered a partnership agreement with Orna Therapeutics for discovering, developing and marketing various programmes based on next-generation RNA technology. Merck will also make royalty payments on any approved products developed out of the partnership.

Vaccines 59

Vaccines Research Laboratories Packaging 59

PharmaShots

JANUARY 23, 2023

Until recently, there were very few topical options available for treating plaque psoriasis long-term. Typically, some patients start with topical steroids; however, these can be challenging, as many are limited by where they can be applied on the body and for how long and how often they can be used. [i] of VTAMA cream?

FDA 40

FDA Labelling Immunization 40

Pharmaceutical Technology

MARCH 30, 2023

The topical and oral form of the compound is intended to treat glaucoma and dry age-related macular degeneration (AMD), as well as other ophthalmic indications with high unmet medical need, in Africa, the Middle East, the Americas and Europe.

Compounding 52

Compounding 52

pharmaphorum

AUGUST 17, 2021

Watch the video below to hear more on those topics and to find out more about PureTech’s interest in digital health, how that lines up alongside its focus on medicines, and some of the biotech company’s key partnerships. About the interviewee. Daphne Zohar is PureTech’s founder and CEO and a member of its board of directors.

Communication 110

Communication Immunization 110

Roots Analysis

AUGUST 14, 2023

Among these agreements, technology integration agreement has emerged as the most popular (~25%) type of partnership. Below, I have pasted figure that depicts key partnership trends along with some recent examples of agreements in this domain.

Packaging 52

Packaging 52

Pharmaceutical Technology

APRIL 12, 2023

The partnership will facilitate the quick development of a preclinical proof of concept programme for the treatment of T1D using Imagine Pharma’s AIPCs as the cell source, together with LyGenesis’ use of the lymph node as a bioreactor capable of growing a functioning ectopic pancreas.

98

98